Viewing Study NCT02532868


Ignite Creation Date: 2025-12-24 @ 5:46 PM
Ignite Modification Date: 2026-01-01 @ 7:11 AM
Study NCT ID: NCT02532868
Status: TERMINATED
Last Update Posted: 2015-08-26
First Post: 2014-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module